Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.91
+0.17 (1.95%)
At close: Sep 26, 2025, 4:00 PM EDT
8.91
0.00 (0.00%)
After-hours: Sep 26, 2025, 7:00 PM EDT
Emergent BioSolutions Stock Forecast
Stock Price Forecast
The 2 analysts that cover Emergent BioSolutions stock have a consensus rating of "Strong Buy" and an average price target of $13.5, which forecasts a 51.52% increase in the stock price over the next year. The lowest target is $12 and the highest is $15.
Price Target: $13.5 (+51.52%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Emergent BioSolutions stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +68.35% | Sep 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +68.35% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +68.35% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +68.35% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +68.35% | Jan 21, 2025 |
Financial Forecast
Revenue This Year
794.97M
from 1.04B
Decreased by -23.82%
Revenue Next Year
947.89M
from 794.97M
Increased by 19.24%
EPS This Year
1.20
from -3.60
EPS Next Year
1.54
from 1.20
Increased by 27.73%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | 830.7M | 1.3B | ||
| Avg | 795.0M | 947.9M | ||
| Low | 767.4M | 668.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2029 |
|---|---|---|---|---|
| High | -20.4% | 57.9% | ||
| Avg | -23.8% | 19.2% | ||
| Low | -26.5% | -15.9% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 1.25 | 1.60 |
| Avg | 1.20 | 1.54 |
| Low | 1.17 | 1.49 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 32.8% |
| Avg | - | 27.7% |
| Low | - | 23.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.